Publications from the Carcinogenic Potency Project

Gold, L.S., Ward, J.M., Bernstein, L., and Stern, B. Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays. Fundam. Appl. Toxicol. 6: 677-690 (1986).

Carcinogenic potency (TD50) estimated from the results of 88 National Cancer Institute/National Toxicology Program (NCI/NTP) carcinogenesis bioassays was examined by common target sites in rats and mice. Other indicators of a chemical's hazard were investigated, including: whether tumors were induced at more than one site in a single sex-species group of test animal, whether tumors may have caused the death of the animal or were found at sacrifice, and whether metastases of induced tumors occurred. These hazard indicators are sometimes interrelated; however, the potency (TD50) values of chemicals which are hazardous by each of these measures spanned a wide range. Carcinogens which caused some type of fatal tumor were more likely than other carcinogens to cause tumors in multiple organ sites and multiple sex-species groups. Since these other hazard indicators were not related to carcinogenic potency, they should be included along with potency estimates such as the TD50 in summarizing the potential dangers of human exposures to a carcinogen and in comparisons of hazard among carcinogens.

Return to the Carcinogenic Potency Project Home Page: Return to home page

Last updated: November 10, 1995

PDF documents are best viewed with the free Adobe® Reader
Excel documents are best viewed with the free Excel® Viewer